Literature DB >> 8386523

Comparison of two different HPLC hydroxylapatite matrices for resolution of IgG idiotypes.

R Vola1, A Lombardi, M Mariani.   

Abstract

High-performance liquid chromatography hydroxylapatite (HPHT) is a well-known matrix utilized to separate macromolecules by differential surface binding to phosphate or calcium sites on the matrix. HPHT columns are commercially available packed with a crystalline structure formed of angular particles conferring a relatively poor elastic resistance to the matrix. In the present paper, we compare a conventional HPHT column to a new ceramic-type hydroxylapatite, which consists of globular particles providing a more mechanically stable matrix. The two hydroxylapatite matrices were compared in the purification of monoclonal antibodies produced by a hybridoma secreting three different types of antibodies. The two HPHT columns were able to separate the three antibodies molecules with equivalent peak resolution, and immunoreactivity analysis identified the active idiotype. HPLC columns packed with the ceramic hydroxylapatite resin exhibited a higher mechanical resistance than the crystalline material allowing significantly higher flow rates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386523

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT).

Authors:  R De Santis; A M Anastasi; V D'Alessio; A Pelliccia; C Albertoni; A Rosi; B Leoni; R Lindstedt; F Petronzelli; M Dani; A Verdoliva; A Ippolito; N Campanile; V Manfredi; A Esposito; G Cassani; M Chinol; G Paganelli; P Carminati
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

2.  Immunoglobulin G in Platelet-Derived Wound Healing Factors.

Authors:  Elisa Seria; Sarah Samut Tagliaferro; Doreen Cutajar; Ruth Galdies; Alex Felice
Journal:  Biomed Res Int       Date:  2021-01-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.